These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 28617442

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Acetyl-11-keto-β-boswellic acid attenuates titanium particle-induced osteogenic inhibition via activation of the GSK-3β/β-catenin signaling pathway.
    Xiong L, Liu Y, Zhu F, Lin J, Wen D, Wang Z, Bai J, Ge G, Xu C, Gu Y, Xu Y, Zhou J, Geng D.
    Theranostics; 2019; 9(24):7140-7155. PubMed ID: 31695758
    [Abstract] [Full Text] [Related]

  • 3. GSK-3β inhibition suppresses instability-induced osteolysis by a dual action on osteoblast and osteoclast differentiation.
    Amirhosseini M, Madsen RV, Escott KJ, Bostrom MP, Ross FP, Fahlgren A.
    J Cell Physiol; 2018 Mar; 233(3):2398-2408. PubMed ID: 28731198
    [Abstract] [Full Text] [Related]

  • 4. Melatonin attenuates titanium particle-induced osteolysis via activation of Wnt/β-catenin signaling pathway.
    Ping Z, Hu X, Wang L, Shi J, Tao Y, Wu X, Hou Z, Guo X, Zhang W, Yang H, Xu Y, Wang Z, Geng D.
    Acta Biomater; 2017 Mar 15; 51():513-525. PubMed ID: 28088671
    [Abstract] [Full Text] [Related]

  • 5. Tension force-induced bone formation in orthodontic tooth movement via modulation of the GSK-3β/β-catenin signaling pathway.
    Mao Y, Wang L, Zhu Y, Liu Y, Dai H, Zhou J, Geng D, Wang L, Ji Y.
    J Mol Histol; 2018 Feb 15; 49(1):75-84. PubMed ID: 29224185
    [Abstract] [Full Text] [Related]

  • 6. GLP-1 promotes osteogenic differentiation of human ADSCs via the Wnt/GSK-3β/β-catenin pathway.
    Li Y, Fu H, Wang H, Luo S, Wang L, Chen J, Lu H.
    Mol Cell Endocrinol; 2020 Sep 15; 515():110921. PubMed ID: 32615283
    [Abstract] [Full Text] [Related]

  • 7. Icariin attenuates titanium-particle inhibition of bone formation by activating the Wnt/β-catenin signaling pathway in vivo and in vitro.
    Wang J, Tao Y, Ping Z, Zhang W, Hu X, Wang Y, Wang L, Shi J, Wu X, Yang H, Xu Y, Geng D.
    Sci Rep; 2016 Mar 31; 6():23827. PubMed ID: 27029606
    [Abstract] [Full Text] [Related]

  • 8. Pharmaceutical inhibition of glycogen synthetase kinase 3 beta suppresses wear debris-induced osteolysis.
    Geng D, Wu J, Shao H, Zhu S, Wang Y, Zhang W, Ping Z, Hu X, Zhu X, Xu Y, Yang H.
    Biomaterials; 2015 Nov 31; 69():12-21. PubMed ID: 26275858
    [Abstract] [Full Text] [Related]

  • 9. Connexin 43 Modulates Osteogenic Differentiation of Bone Marrow Stromal Cells Through GSK-3beta/Beta-Catenin Signaling Pathways.
    Lin FX, Zheng GZ, Chang B, Chen RC, Zhang QH, Xie P, Xie D, Yu GY, Hu QX, Liu DZ, Du SX, Li XD.
    Cell Physiol Biochem; 2018 Nov 31; 47(1):161-175. PubMed ID: 29763908
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of glycogen synthase kinase-3beta attenuates glucocorticoid-induced bone loss.
    Wang FS, Ko JY, Weng LH, Yeh DW, Ke HJ, Wu SL.
    Life Sci; 2009 Nov 04; 85(19-20):685-92. PubMed ID: 19782693
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of protein phosphatase 2A attenuates titanium-particle induced suppression of bone formation.
    Wang L, Bai J, Wang Q, Ge G, Lin J, Xu N, Xu C, Xu Y, Wang Y, Geng D.
    Int J Biol Macromol; 2020 Jan 01; 142():142-151. PubMed ID: 31521663
    [Abstract] [Full Text] [Related]

  • 12. PKR plays a positive role in osteoblast differentiation by regulating GSK-3β activity through a β-catenin-independent pathway.
    Yoshida K, Okamura H, Ochiai K, Hoshino Y, Haneji T, Yoshioka M, Hinode D, Yoshida H.
    Mol Cell Endocrinol; 2012 Sep 25; 361(1-2):99-105. PubMed ID: 22484461
    [Abstract] [Full Text] [Related]

  • 13. Icariin attenuates titanium particle-induced inhibition of osteogenic differentiation and matrix mineralization via miR-21-5p.
    Lian F, Zhao C, Qu J, Lian Y, Cui Y, Shan L, Yan J.
    Cell Biol Int; 2018 Aug 25; 42(8):931-939. PubMed ID: 29500883
    [Abstract] [Full Text] [Related]

  • 14. Effects of WNT1 c.110 T>C and c.505G>T mutations on osteoblast differentiation via the WNT1/β-catenin signaling pathway.
    Zhang B, Li R, Wang W, Zhou X, Luo B, Zhu Z, Zhang X, Ding A.
    J Orthop Surg Res; 2021 Jun 02; 16(1):359. PubMed ID: 34078411
    [Abstract] [Full Text] [Related]

  • 15. Microtubule actin crosslinking factor 1 promotes osteoblast differentiation by promoting β-catenin/TCF1/Runx2 signaling axis.
    Hu L, Su P, Yin C, Zhang Y, Li R, Yan K, Chen Z, Li D, Zhang G, Wang L, Miao Z, Qian A, Xian CJ.
    J Cell Physiol; 2018 Feb 02; 233(2):1574-1584. PubMed ID: 28621459
    [Abstract] [Full Text] [Related]

  • 16. Fisetin promotes osteoblast differentiation and osteogenesis through GSK-3β phosphorylation at Ser9 and consequent β-catenin activation, inhibiting osteoporosis.
    Molagoda IMN, Kang CH, Lee MH, Choi YH, Lee CM, Lee S, Kim GY.
    Biochem Pharmacol; 2021 Oct 02; 192():114676. PubMed ID: 34256044
    [Abstract] [Full Text] [Related]

  • 17. Adiponectin receptor 1 regulates bone formation and osteoblast differentiation by GSK-3β/β-catenin signaling in mice.
    Lin YY, Chen CY, Chuang TY, Lin Y, Liu HY, Mersmann HJ, Wu SC, Ding ST.
    Bone; 2014 Jul 02; 64():147-54. PubMed ID: 24713193
    [Abstract] [Full Text] [Related]

  • 18. Reduction of SOST gene promotes bone formation through the Wnt/β-catenin signalling pathway and compensates particle-induced osteolysis.
    Zhang ZH, Jia XY, Fang JY, Chai H, Huang Q, She C, Jia P, Geng C, Xu W.
    J Cell Mol Med; 2020 Apr 02; 24(7):4233-4244. PubMed ID: 32134561
    [Abstract] [Full Text] [Related]

  • 19. Pentamidine Inhibits Titanium Particle-Induced Osteolysis In Vivo and Receptor Activator of Nuclear Factor-κB Ligand-Mediated Osteoclast Differentiation In Vitro.
    Ihn HJ, Kim K, Cho HS, Park EK.
    Tissue Eng Regen Med; 2019 Jun 02; 16(3):265-273. PubMed ID: 31205855
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of glycogen synthase kinase-3β targeting against osteosarcoma via activation of β-catenin.
    Shimozaki S, Yamamoto N, Domoto T, Nishida H, Hayashi K, Kimura H, Takeuchi A, Miwa S, Igarashi K, Kato T, Aoki Y, Higuchi T, Hirose M, Hoffman RM, Minamoto T, Tsuchiya H.
    Oncotarget; 2016 Nov 22; 7(47):77038-77051. PubMed ID: 27780915
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.